211 related articles for article (PubMed ID: 7635954)
1. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
2. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
Warshawsky I; Bu G; Schwartz AL
J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
[TBL] [Abstract][Full Text] [Related]
5. Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
Lansink M; Jong M; Bijsterbosch M; Bekkers M; Toet K; Havekes L; Emeis J; Kooistra T
Blood; 1999 Aug; 94(4):1330-6. PubMed ID: 10438721
[TBL] [Abstract][Full Text] [Related]
6. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
9. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
10. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity.
Goedde MF; Grimbergen JM; Toet KH; Sitter T; Quax PH; Kooistra T
Kidney Int; 2001 Jul; 60(1):117-25. PubMed ID: 11422743
[TBL] [Abstract][Full Text] [Related]
12. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
Bu G; Maksymovitch EA; Schwartz AL
J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
[TBL] [Abstract][Full Text] [Related]
14. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
Noorman F; Braat EA; Rijken DC
Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
[TBL] [Abstract][Full Text] [Related]
15. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
Stang E; Roos N; Schlüter M; Berg T; Krause J
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein (LRP).
Sánchez MC; Chiabrando GA; Vides MA
Arch Biochem Biophys; 2001 May; 389(2):218-22. PubMed ID: 11339811
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
Rijken DC; Otter M; Kuiper J; van Berkel TJ
Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
[TBL] [Abstract][Full Text] [Related]
19. Clearance receptors for tissue-type plasminogen activator.
Camani C; Kruithof EK
Int J Hematol; 1994 Aug; 60(2):97-109. PubMed ID: 7948967
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
Iadonato SP; Bu G; Maksymovitch EA; Schwartz AL
Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
